ArticleOncotarget2018

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer.

Francesca Toffalorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.